Cargando…

Effect of Thyrotropin Suppression Therapy on Bone in Thyroid Cancer Patients

BACKGROUND. The thyroid cancer incidence is rising. Despite current guidelines, controversy exists regarding the degree and duration of thyrotropin suppression therapy. Also, its potential skeletal effects remain a concern to physicians caring for thyroid cancer patients. We conducted a review of pu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papaleontiou, Maria, Hawley, Sarah T., Haymart, Megan R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AlphaMed Press 2016
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746080/ https://www.ncbi.nlm.nih.gov/pubmed/26659220 http://dx.doi.org/10.1634/theoncologist.2015-0179

Ejemplares similares

Risk of Osteoporosis and Fractures in Patients with Thyroid Cancer: A Case‐Control Study in U.S. Veterans
por: Papaleontiou, Maria, et al.
Publicado: (2019)

Application and prospect of trabecular bone score in differentiated thyroid cancer patients receiving thyrotropin suppression therapy
por: Ran, Bingyu, et al.
Publicado: (2022)

OR21-06 Physician Management of Thyroid Cancer Patients’ Worry: Is It “Good” Enough?
por: Papaleontiou, Maria, et al.
Publicado: (2020)

MON-599 Physician Reported Challenges in the Management of Hypothyroidism
por: Esfandiari, Nazanene Helen, et al.
Publicado: (2019)

Age-based factors modulating the required thyroxine dose to achieve thyrotropin suppression in intermediate-and high-risk papillary thyroid cancer
por: Zhou, Ruo-Yun, et al.
Publicado: (2023)

Interfering Medications in Older Adults on Thyroid Hormone Replacement: Who Is at Risk?
por: Beeson, Rachel, et al.
Publicado: (2021)

The risk between thyrotropin suppression and bone mineral density in differentiated thyroid cancer
por: Zou, Yang, et al.
Publicado: (2022)

Serum Thyrotropin and Phase of the Menstrual Cycle
por: Benvenga, Salvatore, et al.
Publicado: (2017)

Optimal Thyrotropin Suppression Therapy in Low-Risk Thyroid Cancer Patients after Lobectomy
por: Lee, Yu-Mi, et al.
Publicado: (2019)

β-Arrestin 1 in Thyrotropin Receptor Signaling in Bone: Studies in Osteoblast-Like Cells
por: Boutin, Alisa, et al.
Publicado: (2020)

Can Thyrotropin, Tri-Iodothyronine, and Thyroxine Hormones be Predictors of Cancer in Thyroid Lesions?
por: Khider, Mohamed O, et al.
Publicado: (2022)

Association of Thyroid Hormone Treatment Intensity With Cardiovascular Mortality Among US Veterans
por: Evron, Josh M., et al.
Publicado: (2022)

Effect of thyrotropin suppressive therapy on heart rate variability and QT dispersion in patients with differentiated thyroid cancer
por: Liu, Chunhua, et al.
Publicado: (2020)

Thyrotropin Stimulates Differentiation Not Proliferation of Normal Human Thyrocytes in Culture
por: Morgan, Sarah J., et al.
Publicado: (2016)

THU231 Thyroid Function And Childhood Bone Mineral Density: Abnormal Thyrotropin Concentration May Be Another Predictor Of Pediatric Low Bone Mass
por: Ahn, Moon Bae
Publicado: (2023)

Effects of thyrotropin suppression on lumbar bone mineral density in postmenopausal women with differentiated thyroid carcinoma
por: Zhang, Pei, et al.
Publicado: (2018)

Tanycytes and the Control of Thyrotropin-Releasing Hormone Flux Into Portal Capillaries
por: Rodríguez-Rodríguez, Adair, et al.
Publicado: (2019)

Effect of Thyroxine and Thyrotropin on Bone Mineral Density in Postmenopausal Women: A Systematic Review
por: Poudel, Prakar, et al.
Publicado: (2022)

Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves’ Disease
por: Inaba, Hidefumi, et al.
Publicado: (2016)

Taltirelin is a superagonist at the human thyrotropin-releasing hormone receptor
por: Thirunarayanan, Nanthakumar, et al.
Publicado: (2012)

The Role of Thyrotropin Receptor Activation in Adipogenesis and Modulation of Fat Phenotype
por: Draman, Mohd Shazli, et al.
Publicado: (2017)

Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves’ Orbitopathy
por: George, Augustine, et al.
Publicado: (2021)

Benign thyroid nodules respond to a single administration of 0.3mg recombinant human thyrotropin with highly variable volume increase
por: Bountouris, Panagiotis, et al.
Publicado: (2023)

Concurrent Graves' Disease and TSH Secreting Pituitary Adenoma Presenting Suppressed Thyrotropin Levels: A Case Report and Review of the Literature
por: Fu, Jinrong, et al.
Publicado: (2020)

Commentary: Thyrotropin Stimulates Differentiation Not Proliferation of Normal Human Thyrocytes in Culture
por: Kyrilli, Aglaia, et al.
Publicado: (2017)

Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2019)

Unmet Information Needs Among Hispanic Women With Thyroid Cancer
por: Chen, Debbie W, et al.
Publicado: (2021)

Evaluating health outcomes in the treatment of hypothyroidism
por: Ettleson, Matthew D., et al.
Publicado: (2022)

Effects of Thyrotropin Suppression on Bone Health in Menopausal Women with Total Thyroidectomy
por: Kim, Eun Heui, et al.
Publicado: (2019)

Thyrotropin Regulates eNOS Expression in the Endothelium by PGRN Through Akt Pathway
por: Jiang, Fengwei, et al.
Publicado: (2018)

Effect of Thyroid-Stimulating Hormone Suppression on Muscle Function After Total Thyroidectomy in Patients With Thyroid Cancer
por: Lee, Jun Choul, et al.
Publicado: (2021)

Thyrotropin suppression therapy for papillary thyroid carcinoma with a huge recurred neck lymph node
por: Choi, Jung Bum, et al.
Publicado: (2020)

Dynamic Changes in Antithyroperoxidase and Antithyroglobulin Antibodies Suggest an Increased Risk for Abnormal Thyrotropin Levels
por: Li, Yongze, et al.
Publicado: (2020)

Case Report and Literature Review: Ectopic Thyrotropin-Secreting Pituitary Adenoma in the Suprasellar Region
por: Li, Xiaoxu, et al.
Publicado: (2021)

The Two Faces of Janus: Why Thyrotropin as a Cardiovascular Risk Factor May Be an Ambiguous Target
por: Dietrich, Johannes Wolfgang, et al.
Publicado: (2020)

Differential Regulation of the Expression of the Two Thyrotropin Beta Subunit Paralogs by Salmon Pituitary Cells In Vitro
por: Fleming, Mitchell Stewart, et al.
Publicado: (2020)

The Association of Thyrotropin and Autoimmune Thyroid Disease in Developing Papillary Thyroid Cancer
por: Lee, I-Shuan, et al.
Publicado: (2017)

Free Thyroxine Distinguishes Subclinical Hypothyroidism From Other Aging-Related Changes in Those With Isolated Elevated Thyrotropin
por: Abbey, Enoch J., et al.
Publicado: (2022)

Structural–Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at Work
por: Kleinau, Gunnar, et al.
Publicado: (2017)

Meta-analysis of TSH suppression therapy and the risk of cardiovascular events after thyroid cancer surgery
por: Yang, Xiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7nusajtdbfd26fhbi3fujl6akj